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Abstract Dissemination of HIV-1 throughout lymphoid tissues leads to systemic virus spread
following infection. We combined tissue clearing, 3D-immunofluorescence, and electron
tomography (ET) to longitudinally assess early HIV-1 spread in lymphoid tissues in humanized mice.
Immunofluorescence revealed peak infection density in gut at 10–12 days post-infection when
blood viral loads were low. Human CD4+ T-cells and HIV-1–infected cells localized predominantly
to crypts and the lower third of intestinal villi. Free virions and infected cells were not readily
detectable by ET at 5-days post-infection, whereas HIV-1–infected cells surrounded by pools of free
virions were present in ~10% of intestinal crypts by 10–12 days. ET of spleen revealed thousands of
virions released by individual cells and discreet cytoplasmic densities near sites of prolific virus
production. These studies highlight the importance of multiscale imaging of HIV-1–infected tissues
and are adaptable to other animal models and human patient samples.
DOI: 10.7554/eLife.23282.001
Introduction
HIV-1 presents an important global health issue with >36 million people infected worldwide and 2.1
million newly acquired infections in 2015. The majority of new HIV-1 infections result from heterosex-
ual transmission, with women accounting for a majority of all new infections worldwide
(UNAIDS, 2015). During heterosexual transmission of HIV-1, the virus crosses the genital epithelium
and infects a target cell, which results in localized infection, establishment of a latently-infected virus
reservoir, expansion of a local founder population, and systemic virus spread to distant tissues via
lymph and blood (Fackler et al., 2014). With blood containing only 1–2% of HIV-1 target cells in the
body, the majority of HIV-1 target cells in the human body reside within tissues (Guy-Grand and
Vassalli, 1993; Kilby, 2001). Gut-associated lymphoid tissue (GALT), lymph nodes, and spleen con-
tain a large number HIV-1 target cells that support localized virus transmission and remain a key
source of virus replication during systemic spread and long term disease progression (Haase, 1999;
Reinhart et al., 1997; Grossman et al., 1998), yet the biological details of interactions between the
virus and immune cells within tissues remain poorly characterized at single cell and subcellular
resolution.
HIV-1–infected animal models offer an opportunity to investigate virus spread within tissues using
immunofluorescence (IF) and electron microscopy (EM) imaging. Model systems of HIV-1 infection
include both non-human primates (NHP) and mice, with mouse models being more practical for lon-
gitudinal studies of infection in which relatively large numbers of animals are infected. Mice with
humanized immune systems (hu-mice) allow the rapid generation of human target cells infected with
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wildtype virus in a living organism with a functioning immune system and recapitulate important
aspects of HIV-1 pathology including mucosal infection, systemic virus spread, latency, and response
to therapeutic intervention (Hatziioannou and Evans, 2012; Marsden and Zack, 2015).
Optical clearing techniques, originally developed >100 years ago, enabled imaging of large vol-
umes of tissue, which led to an enhanced understanding of human anatomy, but the original clearing
methods are not compatible with modern fluorescence microscopy due to tissue destruction and
quenching of the fluorescent signal (Richardson et al., 2015; Treweek and Gradinaru, 2016;
Tainaka et al., 2016). However, recent advances in optical clearing of intact tissues combined with
3D fluorescence microscopy enable imaging of tissues at single cell resolution (Richardson et al.,
2015; Tainaka et al., 2016). The basic principles of tissue clearing involve removing opaque biomo-
lecules that reduce light penetration into samples and matching the refractive index of optics, solu-
tions, and tissues to minimize optical distortions during imaging. CLARITY/PACT and CUBIC tissue-
clearing techniques were recently applied to render entire rodents optically clear while maintaining
tissue integrity at the single cell level (Chung et al., 2013; Susaki et al., 2014; Tainaka et al., 2014;
Treweek et al., 2015; Yang et al., 2014). When combined with IF and fluorescence microscopy,
these techniques allow imaging of large volumes (mm3–cm3) of intact tissues at single cell resolution,
delineation of the connectivity of biological structures, and discrimination of individual cell types
within complex tissue environments. Tissue clearing techniques were recently applied to image
brain, nervous system, and internal organs in rodents, the spatial heterogeneity of mouse tumor
models, developmental processes in zebrafish, and post-mortem pathology from preserved human
samples (Tainaka et al., 2016; Chung et al., 2013; Susaki et al., 2014; Tainaka et al., 2014;
Tomer et al., 2014; Guldner et al., 2016; Tomer et al., 2015), but have not previously been used
to image lymphoid tissues from HIV-1–infected animals.
EM was originally utilized to identify HIV-1 as the causative agent of AIDS (Barre´-Sinoussi et al.,
1983; Gallo et al., 1983) and has subsequently been applied to examine aspects of HIV-1 pathology
at ultrastructural resolution (Orenstein, 2007). ET can provide 3D information at subcellular resolu-
tion from frozen hydrated or from well-preserved, fixed biological samples (McIntosh et al., 2005).
ET of purified HIV-1 and HIV-1–infected cultured cells have contributed to our understanding of the
HIV-1 life-cycle through investigations of the structures of mature and immature virions
(Benjamin et al., 2005; Briggs et al., 2009; Wright et al., 2007), envelope spike densities and con-
formations on virions (Zhu et al., 2006; Liu et al., 2008), virus biogenesis (Carlson et al., 2010,
2008), cell entry, and cell-to-cell transmission (Earl et al., 2013). Although informative, these studies
provided no information concerning HIV-1 in the context of an infection within a host organism. The
in situ environment involves multiple cell types within tissues and organs, which may alter virus
behavior and fine-structural associations compared to infection within a cultured cell environment. In
a previous study, we combined optimized tissue preservation methods with ET to image HIV-1 in
GALT derived from chronically infected hu-mice (Ladinsky et al., 2014). This approach allowed us to
distinguish and characterize mature, immature, and budding virions, localize infected cells and inter-
cellular pools of free virions within colon crypts, and identify distinct components of virus budding
machinery within infected GALT tissues (Ladinsky et al., 2014). These studies shed light on HIV-1
interactions during later phases of infection, establishing the groundwork for investigations of HIV-1
during critical early virus spread in lymphoid tissues.
Here we address early HIV-1 spread by combining 3D-IF microscopy of optically-cleared tissues
with ET of optimally-preserved tissues. This parallel approach allowed us to image systemic virus
spread in HIV-1–infected hu-mouse lymphoid tissues at different volumes, resolutions, and times
after infection. These analyses provided a longitudinal and spatial comparison of the location, type,
and density of infected cells, routes of virus spread, and virus levels in lymphoid tissues. Infectivity in
GALT and spleen preceded peak blood viremia and showed a rapid and exponential spread of virus
in these tissues early after infection. Blood viral load peaked over a week later, when infectivity in
several lymphoid tissues was beginning to diminish, emphasizing the discrepancy between blood
and tissue infectivity. During times of peak infectivity, large numbers of free virions were identified in
spleen, with individual infected cells being surrounded by >1000 virions within thin volumes of tissue.
These studies provide multiscale information about the early systemic spread of virus within lym-
phoid tissues at both cellular and subcellular resolution, and these methods are readily adaptable to
in situ analysis of HIV-1–infection in other hu-mouse and NHP models, and samples from human
patients.
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Results
Validation of PBMC-NSG hu-mouse model for imaging studies
Perhaps the most accurate hu-mouse model, bone marrow/liver/thymus (BLT) mice, are generated
by transferring CD34+ human stem cells together with human fetal thymic and liver tissues during
individual surgeries into immunocompromised mice (Melkus et al., 2006; Lan et al., 2006). While
BLT mice are optimal for studies of mucosal transmission of HIV-1 (Sun et al., 2007; Denton et al.,
2008), they are not cost effective for longitudinal studies of HIV-1 infection involving large cohorts
of infected animals. We therefore used a technically simpler and less expensive hu-mouse model
constructed by injection of primary human peripheral blood mononuclear cells/lymphocytes (PBMC/
PBL) into NOD.Cg-PrkdscidIl2rgtm1Wjl/SzJ (NSG) mice (Ishikawa et al., 2005; Shultz et al., 2005; ;
King et al., 2008), which are immunocompromised animals lacking mature natural killer cells, B-cells
and T-cells. PBMC-NSG mice rapidly reconstitute human CD4+ and CD8+ T-cells in addition to
human B-cells and disseminate human lymphoid cells to lymph nodes, spleen, bone marrow, genital
mucosa, and intestine (Hatziioannou and Evans, 2012; Marsden and Zack, 2015; Ishikawa et al.,
2005; King et al., 2008; Mosier et al., 1988). It is important to note that the PBMC-NSG hu-mouse
model almost exclusively harbors activated human T cells that can react with host antigens and cause
animals to develop graph versus host disease (Marsden and Zack, 2015). The lack of other cell line-
ages combined with raised levels of T cell activation in this model may enhance the dynamics of HIV
spread and pathogenesis compared to other hu-mouse models that contain a smaller compartment
of activated T cells at the time of infection and a more diverse set of immune cell lineages. Nonethe-
less, the robust reconstitution of activated human T-cells in the PBMC-NSG hu-mouse models is an
important component for HIV-1 studies in hu-mice since (i) CD4+ T-cells make up the majority of all
HIV-1 target cells in humans (Haase, 1999), (ii) activated T cells constitute a sizeable proportion of
all CD4+ T cells in humans (~10%), (iii) activated T cells rise to ~20–40% during the course of HIV-1
infection (Mahalingam et al., 1993), and (iv) activated T cells localize to important tissue sites of
virus pathology including spleen, lymph nodes, and GALT (Saksena et al., 2010; Cerf-
Bensussan and Guy-Grand, 1991). Importantly, HIV-1 infection of PBMC-NSG mice mimics early
stages of infection in humans, in that the virus replicates exponentially, resulting in large scale CD4+
T-cell depletion within a few weeks (Marsden and Zack, 2015; Kim et al., 2016; Kumar et al.,
2008), and this model was previously used to study the effectiveness of anti-HIV-1 therapies in
reducing systemic virus spread after intravenous transmission (Kim et al., 2016; Kumar et al., 2008;
Balazs et al., 2012, 2014; Hur et al., 2012). The lower cost, simplicity, rapid generation of HIV-1–
infected animal cohorts, and effective reconstitution of systemic virus spread make the PBMC-NSG
hu-mouse model advantageous for longitudinal studies investigating early T cell-mediated patho-
genic events in GALT, spleen, and peripheral blood.
HIV-1-infected PBMC-NSG mice normally show robust blood p24 levels ~2–4 weeks post-infection
(PI), followed by a sharp decrease of viral load (Kim et al., 2016; Kumar et al., 2008; Balazs et al.,
2012, 2014). By contrast, blood p24 levels in HIV-1 infected BLT mice regularly peak at ~4–6 weeks
PI, followed by a slower reduction in blood viral load (Sun et al., 2007; Brainard et al., 2009;
Denton et al., 2008). To compare with our previous imaging studies of GALT from long-term (10 to
20 weeks PI) infected BLT mice (Ladinsky et al., 2014), we chose three weeks PI for analysis and
imaging in PBMC-NSG mice to ensure that human cells and virus would still be present in tissues.
Female NSG mice were reconstituted with human PBMCs and three PBMC-NSG mice were infected
with R5-tropic HIV-1 (pNL4-3envYU2). HIV-1 p24 levels in blood showed mean levels of 2.50 ± 0.78
ng/mL at 12 days PI and 12.68 ± 8.05 ng/mL at 21 days PI, demonstrating productive infection in all
three animals (Figure 1A). An infected animal was necropsied at 21 days PI and adjacent GALT sam-
ples from the colon were fixed with aldehydes for parallel IF and ET analysis. IF of colon showed the
presence of human CD3+ cells and HIV-1 p24 in infected animals three weeks PI in colon crypts and
within the crypt epithelium (Figure 1B). ET corroborated the IF results, showing the presence of
infected cells indicated by virus budding profiles projecting from the plasma membrane and free viri-
ons in similar tissue locations (Figure 1C,D). The localization and levels of T-cells and HIV-1 within
colon crypts were consistent with our previous studies in HIV-1–infected BLT animals
(Ladinsky et al., 2014), establishing the validity of the PBMC-NSG model for conducting longitudi-
nal imaging studies of HIV-1 infection and spread in lymphoid tissues.
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Figure 1. HIV-1 infection and Imaging of hu-mice. (A) Mean blood p24 levels from three HIV-1–infected PBMC-NSG mice assessed at 0, 12, and 21 days
PI. Error bars represent standard deviation. (B) IF of GALT from HIV-infected animal with highest blood p24 level from panel A at 21 days PI. Samples
were stained for human CD3 (magenta), HIV-1 p24 (green), and nuclei (blue). White arrows indicate human CD3+/p24+ cells. (C) Montaged projection
EM overview of colon crypt region from the same animal. Areas with virus are highlighted (green asterisks) along with a region of interest for imaging
by ET (yellow box). Virus was found in close proximity to a blood vessel (BV) containing red blood cells (RBCs). (D) Tomographic slice of region of
interest from panel C showing separate pools of free virus on two sides of an infected cell. Black arrows indicate budding virions.
DOI: 10.7554/eLife.23282.002
The following source data is available for figure 1:
Source data 1. Source data for Figure 1A.
DOI: 10.7554/eLife.23282.003
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Tissue clearing and IF imaging of lymphoid tissues
We next sought to obtain spatial information about T-cell localization from multiple tissue types in
PBMC-NSG mice. Optical clearing techniques offer the opportunity to image large volumes of opa-
que tissues by IF without serial sectioning (Richardson et al., 2015). We used different methods for
clarifying tissues: GALT and female reproductive tract (FRT) were cleared using CLARITY/PACT
(Treweek et al., 2015), and spleen samples containing heme were cleared using CUBIC
(Tainaka et al., 2014) (Figure 2A). Tissues from uninfected PBMC-NSG animals were immunostained
and imaged by confocal microscopy using antibodies against human CD3 to evaluate T-cell reconsti-
tution and against HIV-1 p24 to rule out background staining in uninfected animals. IF of cleared
GALT from uninfected animals revealed human CD3+ T-cells in the colon, spleen, and FRT
(Figure 2B). These results established that optically cleared, intact lymphoid tissues from PBMC-
NSG mice could be imaged by IF to detect the presence and localization of human T-cells.
Lymphoid tissue samples from an HIV-infected animal that had a high blood p24 level at 21 days
PI (10.9 ng/mL p24) were cleared and stained to visualize the distribution of human CD3+ T-cells
and HIV-1. Confocal microscopy in different lymphoid tissues from HIV-1–infected PBMC-NSG mice
revealed the presence of human CD3+ T-cells, a subset of which were positive for HIV-1 p24
(Figure 2C). Some regions of p24 staining were not positive for human CD3, representing either
free HIV-1 virions or infected cells other than T cells (Figure 2C).
Longitudinal quantification of GALT infectivity
PBMC-NSG mice were infected and necropsied at specific times during the first six weeks PI
(Figure 3A), and lymphoid tissues were prepared for imaging studies as described above. Cleared
colon samples from HIV-1–infected or mock-infected controls were immunostained and imaged
(Figure 3B). Representative images revealed low levels of infected human CD3+ T-cells at 5 days PI,
which rapidly increased to peak levels at 10–16 days PI, before diminishing at time points >21 days
PI. To enable quantification of T-cell and infection densities, the total number of nuclei in confocal
slices were determined using the Fiji software suite (Schindelin et al., 2012), resulting in an agree-
ment of 96.2 ± 1.9% compared to manual quantification (Figure 3—figure supplement 1). Human
CD3+ T-cells from at least four confocal slices in 1–3 animals at individual time points were manually
quantified in infected and uninfected controls (n > 5000 cells per time point). T-cells in colon from
uninfected PBMC-NSG mice remained near 6% of total cells (Figure 3C), comparable to the ~10–
12% found in uninfected human patient samples (McElrath et al., 2013). Human CD3+ T-cell densi-
ties in HIV-1–infected animals were similar to densities in uninfected controls until 12 days PI, at
which time T-cell levels rapidly dropped to <4% of total cells at 16 days PI and continued to
decrease gradually out to 45 days PI. p24+/human CD3+ T-cells were quantified similarly in GALT,
revealing peak infectivity at 12 days PI, with nearly 3% of cells representing HIV-1–infected T-cells
(Figure 3D). Infectivity levels rapidly decreased to <1% of cells representing infected T-cells after 21
days PI and approached zero by 35 days PI. When compared to p24 levels in blood from the same
animals, the percent of p24+ T-cells peaked at 12 days PI and preceded peak blood p24 levels by 9
days, when p24 levels were low (Figure 3D). At peak blood p24 levels (21 days PI), the percentage
of p24+ T-cells in colon had already diminished to nearly half of maximum levels at 10–12 days PI.
These results are consistent with a disconnect between tissue infectivity and blood viral load over
time, as previously noted in human samples (Anton et al., 2003; Chun et al., 1997). p24 not co-
localized with human CD3+ T-cells was compared to levels of p24 associated with human CD3+
T-cells (Figure 3B,E). This analysis revealed an increase in p24 signal not associated with human
CD3+ T-cells concomitant with decreased infectivity of human CD3+ T-cells at 21 days PI.
Spatial and temporal distributions of HIV-1 in GALT
Intact regions of HIV-1-infected GALT cleared and immunostained for human CD4+ T-cells, human
CD8+ T-cells, and HIV-1 p24 at specific times PI were imaged by confocal microscopy, and catego-
ries of cells in individual Z-slices were quantified (Figure 4). A 45 mm confocal Z-stack from the colon
of an HIV-1–infected hu-mouse at 12 days PI displayed human CD4+ T-cells and p24+ cells localized
to intestinal crypts and the bottom half of villi, whereas human CD8+ T-cells were dispersed uni-
formly throughout the crypts and the length of the villi (Figure 4A,B and Video 1). Mean distances
from the base of crypts were 51.2 ± 34.5 mm for human CD4+ T-cells, 79.2 ± 36.8 mm for human
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Figure 2. Tissue clearing and IF imaging of lymphoid tissues. (A) Representative images of uncleared (left) and cleared (right) lymphoid tissues from
uninfected hu-mice. (B, C) Confocal images of cleared lymphoid tissues from uninfected (panel B) and HIV-1–infected (28 days PI) (panel C) hu-mice
stained with antibodies against human CD3 (magenta) and HIV-1 p24 (green). Nuclei were labeled with DAPI (blue). Scale bars for overview
images = 50 mm. Scale bars for zoomed views = 20 mm.
DOI: 10.7554/eLife.23282.004
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Figure 3. Longitudinal quantification of GALT infectivity. (A) Timeline of immune cell reconstitution, HIV-1 infection, and tissue harvest from hu-mice.
Top numbers depict days PI, bottom numbers show number of animals per timepoint. Single uninfected animals were sacrificed at 0, 21, and 45 days
PI. All other animals were infected and sacrificed at the times indicated. (B) Representative images showing human CD3+ T-cells (magenta), HIV-1 p24
(green), and nuclei (blue) in colon at early (0–5-days PI), peak (10–16 days PI), and late (>21 days PI) infectivity. Arrows indicate infected cells. Asterisks
show p24 not associated with human CD3+ T-cells. (C–E) Error bars represent standard deviation. n > 5000 cells from 1–3 animals for all time points. (C)
Quantification of human CD3+ T-cells as the percent of total cells for HIV-1–infected (black line) or uninfected (gray line) animals. (D) Comparison of
GALT infectivity as percent infected cells of total (black line, left Y-axis) with blood p24 (gray line, right Y-axis, ng/mL) levels over time. (E) Longitudinal
profile of percent HIV-1 p24-positive human CD3+ T-cells (black line, left Y-axis) and percent of p24 signal not associated with human CD3+ T-cells
(gray line, right Y-axis).
DOI: 10.7554/eLife.23282.005
The following source data and figure supplement are available for figure 3:
Figure 3 continued on next page
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CD8+ T-cells, and 47.9 ± 45.1 mm for p24+ cells (Figure 4C). The localization of HIV-1–infected cells
to colon crypts is consistent with our previous EM and IF studies of later stages of HIV-1 infection in
GALT from BLT hu-mice (Ladinsky et al., 2014) and with results from early SIV infection in rhesus
macaques (Hirao et al., 2014). The spatial arrangement of these cell types remained constant during
the course of the experiment (Figure 4D), even as the total numbers of human CD4+ T-cells and
p24+ cells markedly decreased at late time points (Figure 4E), likely due to target cell depletion.
ET of longitudinal HIV-1 spread in GALT
To gain ultrastructural information about systemic virus spread in GALT, sections of HIV-1–infected
colon were imaged by EM at representative time points (Figure 5A). Tissue samples adjacent to
those used for IF were imaged in parallel by ET, as opposed to directly imaging the same tissue sam-
ple using both IF and EM, because the methods for extracting lipids from cleared tissues for IF elimi-
nates scaffolding within the cell, resulting in destruction of ultrastructural details at the EM level
(Treweek et al., 2015). EM surveys of colon crypts, where we previously characterized active HIV-1
infection by ET in a BLT hu-mouse model (Ladinsky et al., 2014), confirmed the infectious profile
depicted by IF (Figure 5A and B). Early after infection (5 days PI), infected cells and free virus were
not readily detected. This was followed by an exponential increase in the number of infected cells
and the presence of large extracellular pools of free virus, often containing >100 free virions within
200–400 nm thick regions of tissue during peak infectivity (10–16 days PI). At this time, ~10% of
crypts showed signs of active infection cells as evidenced by cells with budding virions attached to
the plasma membrane (Figure 5B; center panel). At later times (>21 days PI), the total number of
infected cells was reduced and individual pools of free virus in similar locations contained fewer viri-
ons. Most of the pools of free virus were not associated with actively-infected cells, consistent with
our IF observation that levels of HIV-1 p24 not associated with human CD3+ T-cells increased at later
time points PI (Figure 3B and E). These results suggested that most of the p24+/CD3- cells
detected by IF at late times PI represented pools of free-virions, rather than infected cells other than
T cells.
A cross section of a colon villus highlighting a vascularized central channel of lamina propria from
an HIV-1–infected hu-mouse 10 days PI revealed large pools of virus (Figure 5C; left and center pan-
els). Pools of virus in lamina propria were often found near vasculature, and ET allowed tracing of a
virus-containing lateral intercellular space in 3D exhibiting pools of virus with openings leading to
the walls of blood vessels (Figure 5C; right panels and Video 2).
Parallel IF and ET of HIV-1 infection in spleen
We next imaged HIV-1 in spleen, first verifying that this organ in PBMC-NSG hu-mice exhibited char-
acteristic architectural features. Splenic tissue can be histologically divided into regions of red and
white pulp (Mebius and Kraal, 2005). Red pulp makes up a majority of the volume of the spleen,
contains large numbers of red blood cells (RBCs) generating a red hue, and primarily functions to fil-
ter the blood. White pulp contains large numbers of B- and T-cells that coordinate immune
responses within the blood. As such, spleen harbors large quantities of HIV-1 target cells, making it
an important organ for HIV-1 pathology (Mebius and Kraal, 2005; Ganusov and De Boer, 2007;
Langeveld et al., 2006). Indeed, a longitudinal study of SIV infection in NHP spleen revealed large
numbers of HIV-1–infected CD4+ T-cells during acute infection that resulted in T-cell depletion and
morphological changes in tissue at later stages of infection (Williams et al., 2016), consistent with
human autopsy studies (Diaz et al., 2002).
Figure 3 continued
Source data 1. Source data for Figure 3C.
DOI: 10.7554/eLife.23282.006
Source data 2. Source data for Figure 3D.
DOI: 10.7554/eLife.23282.007
Source data 3. Source data for Figure 3E.
DOI: 10.7554/eLife.23282.008
Figure supplement 1. Validation of automated quantification of nuclei.
DOI: 10.7554/eLife.23282.009
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Figure 4. Spatial distribution of HIV-1 infection in GALT over time. (A) Representative confocal slice from 45 mm Z-stack depicting the distribution of
human CD4+ T-cells (magenta), HIV-1 p24 (green), human CD8+ T-cells (red) and nuclei (blue) in colon at 12-days PI. (B) Zoom of boxed region in panel
A showing individual channels and merged view for human CD4+ T-cells, human CD8+ T-cells, and p24. (C–E) Error bars represent standard deviation.
(C) Quantification of Z-stack from panel A showing the distance (mm) from the base of crypts of human CD4+ T-cells (magenta), human CD8+ T-cells
Figure 4 continued on next page
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To determine if splenic tissue from hu-mice could be used to investigate HIV-1 infection, we
imaged spleens from wildtype, NSG, and PBMC-NSG mice by brightfield, LM and EM to determine
levels of human T-cell reconstitution and compare splenic architectures (Figure 6 and Figure 6—fig-
ure supplement 1). Bright-field images of wildtype spleen showed the presence of round foci of
white pulp separated by regions of red pulp (Figure 6—figure supplement 1). EM of white pulp
from wildtype animals revealed diverse cell types, including lymphocytes, and collagen deposits. In
contrast, brightfied microscopy of spleen from non-reconstituted NSG animals showed little to no
white pulp, and EM of these samples indicated different cell types, denser packing, and little colla-
gen (Figure 6—figure supplement 1). Brightfield microscopy images of uninfected PBMC-NSG ani-
mals revealed regions of white pulp at greater levels than non-reconstituted NSG animals, but these
were not organized into foci as in wildtype spleen. IF of uninfected PBMC-NSG spleen showed local-
ized pockets of human CD3+ T-cells interspersed throughout volumes of splenic tissue (Figures 2B
and 6A; left panels). Montaged projection EM surveys of uninfected PBMC-NSG spleen demon-
strated delineations between white pulp and red pulp regions (Figure 6B; left panels and Figure 6—
figure supplement 1). Red pulp contained enu-
cleated RBCs, while white pulp was distin-
guished by an absence of RBCs, bundles of
collagen fibrils, and populations of lymphocytes
identified as cells with large, dense nuclei sur-
rounded by minimal cytoplasm. Overall, the
organization of the spleen in PBMC-NSG hu-
mice was intermediary between non-reconsti-
tuted NSG animals and wildtype immunocompe-
tent animals, with white pulp occurring as
smaller striations within the red pulp as opposed
to the circular foci seen in spleens from wildtype
animals (Figure 6—figure supplement 1). These
results demonstrated that structural and cellular
components of splenic white pulp, most impor-
tantly HIV-1 target cells, are present in PBMC-
NSG animals even though the splenic architec-
ture is altered.
To evaluate the distribution of virus and
T-cells, adjacent samples of spleen from an HIV-
1–infected PBMC-NSG animal at 12 days PI were
imaged by IF and EM. IF of spleen revealed the
presence of human CD3+ T-cells in addition to
sporadic foci of HIV-1 p24 distributed through-
out large regions of tissue (Figure 6A, right pan-
els). EM of spleen from the same animal showed
discernable regions of white pulp containing
Figure 4 continued
(red), and p24+ T-cells (green) for the volume in panel A. * indicates p<0.0001 (unpaired t-test with Welch’s correction, two-tailed). (D) Quantification of
distance (mm) from the base of crypts for human CD4+ T-cells (magenta), human CD8+ T-cells (red), and p24+ T-cells (green) for individual volumes
during times of early, peak, and late infectivity. n > 2000 total cells for each volume. (E) Quantification of CD4+ T-cells (magenta), human CD8+ T-cells
(red), and p24+ T-cells (green) as a percentage of total cells at early, peak, and late infectivity times. n > 5000 total cells for each time point.
DOI: 10.7554/eLife.23282.010
The following source data is available for figure 4:
Source data 1. Source data for Figure 4C.
DOI: 10.7554/eLife.23282.011
Source data 2. Source data for Figure 4D.
DOI: 10.7554/eLife.23282.012
Source data 3. Source data for Figure 4E.
DOI: 10.7554/eLife.23282.013
Video 1. Spatial Distribution of HIV-1 and T-cells in
GALT 360˚ rotation of a 45 mm thick Z-stack depicting
the spatial distribution of human CD4+ T-cells
(magenta), HIV-1 p24 (green), human CD8+ T-cells (red)
and nuclei (blue) in colon at 12-days PI. Crypts are at
the base and villus tips extend toward the top of the
volume. Quantification of this volume is reported in
Figure 4A–C.
DOI: 10.7554/eLife.23282.014
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Figure 5. Electron tomography of longitudinal HIV-1 spread in GALT. (A, B) Montaged overview EM projection images (panel A) and zoomed
tomographic slices (panel B) of HIV-1–infected colon crypts from hu-mice from early (5 days), peak (10–16 days), and late (>21 days) time points PI.
Arrows indicate pools of free virions between cells. (C) Lamina propria from HIV-1 infected GALT 10 days PI. Left: montaged overview EM projection
image showing lamina propria in cross-section. Arrows indicate blood vessels containing red blood cells. Yellow box indicates zoomed region of
Figure 5 continued on next page
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infected lymphocytes intercalated within bundles of collagen fibrils and surrounded by HIV-1 virions
(Figure 6B; right panel and Figure 7A,B; top panels). ET of an HIV-1–infected cell from spleen 12
days PI revealed prolific virus production at distinct regions of plasma membrane (Figure 7A). Serial
section tomographic reconstruction of a 6.9 mm x 3.5 mm x 0.8 mm (19.3 mm3) volume from a single
infected cell contained nearly 1000 virus particles of which 846 were mature, 18 were immature, and
102 were budding from the cell surface (Figure 7A and Video 3). By approximating the volume of
an entire cell as an ellipsoid, we used this result to calculate that a single cell could produce >6000
virions during a single round of virus production. A reconstructed 3.4 mm x 3.4 mm x 1.2 mm (13.9
mm3) volume from another HIV-1–infected cell in spleen at the same time PI revealed 1350 virus par-
ticles with 1329 mature, 15 immature, six budding virions, and predicted >4000 virions released
(Figure 7B).
HIV-1 budding machinery
VPS4 is a hexameric AAA+ ATPase (Monroe et al., 2014) recruited by the endosomal sorting com-
plex required for transport (ESCRT) protein network to enable the fission of membranes during cellu-
lar processes including cell division, endosomal sorting, and virus budding (Sundquist and
Kra¨usslich, 2012). In previous ET studies of HIV-1 infection in GALT from BLT hu-mice, we identified
discreet densities localized at the base of budding virions and proposed that they included VPS4
oligomers (Ladinsky et al., 2014). We found similar densities localizing to the base of budding viri-
ons in tomograms of splenic tissue from HIV-1-infected PBMC-NSG mice at 12 days PI (Figure 8A).
Immuno-EM using an anti-VPS4 antibody showed localization of VPS4 to the base of budding virions
(Figure 8B), demonstrating that VPS4 localizes to the same region, suggesting that the densities
include VPS4, perhaps in complex with other proteins.
In some cells, ET revealed large numbers of virions (>100 budding profiles) produced from dis-
tinct regions of the plasma membrane of HIV-1–
infected cells (Figure 8C). In the cytoplasm
immediately adjacent to these sites of prolific
virus release, we found accumulations of large
numbers of densities indistinguishable from the
densities near budding virions (Figures 8C,D
and 9). These cytoplasmic densities were found
in direct proximity (within 1 mm of the plasma
membrane) to large numbers of budding virions
and contained hundreds to thousands of densi-
ties within an individual accumulation. As the
cytoplasmic accumulations of these densities
were rare, we were unable to prepare analogous
negatively-stained samples for immuno-EM.
However, we ruled out identification of the den-
sities as ribosomes, since they were more elec-
tron dense than neighboring ribosomes and also
lacked the characteristic cleft between the small
and large ribosomal subunits (Figure 9).
The cytoplasmic densities were not found in
infected lymphocytes in the splenic white pulp
that were surrounded by large pools of free viri-
ons but displayed few budding profiles (<10
buds); large cytoplasmic pools of density were
absent in a cell that exhibited only six budding
profiles (some of which also included the
Figure 5 continued
interest depicted in middle panel. Zoomed region from overview reveals pools of virus adjacent to vasculature. Right: tomographic slices of two
indicated regions (arrows) that reveal pools of virus contiguous with blood vessel walls connected by lateral intercellular space.
DOI: 10.7554/eLife.23282.015
Video 2. ET of a pool of virions in GALT at peak
infectivity Tomographic reconstruction of a volume of
two consecutive 400 nm serial sections from colon of a
PBMC-NSG animal 10-days PI (Figure 5C, upper right
panel). A pool of virions resides in the center with the
lateral intercellular space between two cells extending
into the upper right portion of the movie and is
contiguous with a blood vessel wall (Figure 5C, center
panel). Scale bar = 0.5 mm.
DOI: 10.7554/eLife.23282.016
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densities at the bases of the buds) but was surrounded by >1000 free extracellular virions
(Figure 8D). Indeed, accumulations of cytoplasmic densities were only seen in cells undergoing pro-
lific virus budding, and in these cells, only in regions adjacent to the buds (Figure 8D and Video 4).
These results suggest that cytoplasmic pools of these densities accumulate during periods of prolific
virus production and are exhausted following a round of virus release.
Discussion
Here we combined tissue clearing, 3D-IF microscopy, and ET to longitudinally assess T-cell systemic
spread of HIV-1 in a hu-mouse model of HIV-1 infection at multiple levels of volume and resolution.
Tissue clearing and IF microscopy allowed interrogation of volumes of intact tissues at single cell res-
olution. This approach provided information about the spatial distribution of human immune cells,
HIV-1–infected cells, and virus proteins within multiple tissues from PBMC-NSG hu-mice at specific
times after infection. ET of adjacent tissue regions allowed imaging at subcellular resolution and vali-
dated infectivity patterns identified by IF. These studies revealed a rapid and vast spread of virus
throughout GALT and spleen at times when virus in blood was barely detectable.
Figure 6. Parallel IF and ET of HIV-1 infection in spleen. (A) Confocal IF images of cleared spleen showing human CD3+ T-cells (magenta), HIV-1 p24
(green), and nuclei (blue) from an uninfected (-HIV) or infected (+HIV) animal at 12-days PI. Yellow boxes indicate areas of zoomed views. White arrows
indicate regions with p24. (B) Montaged overview EM projection images from adjacent regions of spleen from the same animals in A. Yellow dashed
lines depict regions of white pulp, black arrows indicate red blood cells in a region of red pulp, white arrowhead shows an HIV-1-infected cell.
DOI: 10.7554/eLife.23282.017
The following figure supplement is available for figure 6:
Figure supplement 1. Architecture of the spleen in wildtype, NSG, and PBMC-NSG mice.
DOI: 10.7554/eLife.23282.018
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Figure 7. ET and modeling of HIV-1 Infection in spleen. (A and B) EM projection images of HIV-1-infected cells from regions of spleen from an HIV-1-
infected animal 12-days PI (top panels). Collagen fibrils (white arrows) and pools of virions (black arrows) surround the infected cells. Yellow boxes
indicate regions of tomographic reconstruction. Tomographic slices show zoomed detail of infected cells (middle panels). Modeled mature (green),
immature (blue), and budding (magenta) virions from the full volume of tomographic reconstructions (bottom panels). Scale bars for tomogram and
model panels are 0.5 m.
DOI: 10.7554/eLife.23282.019
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One focus of these studies was GALT, an
important site for early aspects of HIV-1 interac-
tion with the immune system that is home to a
large proportion of HIV-1 target cells and is criti-
cal for early establishment of HIV-1 infection and
pathogenic effects that lead to long-term disease
progression (Guy-Grand and Vassalli, 1993;
Saksena et al., 2010; Cerf-Bensussan and Guy-
Grand, 1991; Belmonte et al., 2007;
Mestecky et al., 2009). Tissue clearing and 3D-IF
allowed the quantification of human T-cells and
HIV-1–infected cells within intact GALT from
PBMC-NSG hu-mice (Figure 3) and revealed a
human CD3+ T-cell density that was comparable
to those from human patient colon samples
(McElrath et al., 2013). Furthermore, human
T-cells were found in intestinal crypts, in agree-
ment with results from HIV-1–infected colon sam-
ples from BLT hu-mice (Ladinsky et al., 2014),
colon samples from SIV-infected NHP
(Mohan et al., 2007), and uninfected human
colon samples (McElrath et al., 2013), validating
the PBMC-NSG hu-mouse model for studying HIV-1 infection of human T-cells in GALT. Longitudinal
quantification of infectivity in GALT revealed the dynamics of HIV-1 infectivity over time. Peak infec-
tivity in GALT occurred while levels of virus in the blood, a hallmark of HIV-1 progression, were quite
low. GALT infectivity then rapidly decreased and coincided with a drop in human CD3+ T-cell den-
sity in HIV-1–infected animals (Figure 3C,D), consistent with studies in humans showing T-cell deple-
tion in GALT during acute HIV-1 infection (Brenchley et al., 2004; Mehandru et al., 2004). In our
previous ET study of HIV-1-infection in GALT from BLT animals, all samples were from 10–20 weeks
PI, yet HIV-1 and infected T cells were present (Ladinsky et al., 2014). The more rapid dynamics of
virus spread and target cell depletion in GALT of HIV-1–infected PBMC-NSG hu-mice could be due
to the high levels of T cell activation and a lack of T cell replenishment in PBMC-NSG animals
(Marsden and Zack, 2015).
In the colon of HIV-1–infected animals, human CD4+ T-cells preferentially localized to the bottom
third of villi and in crypts whereas human CD8+ T-cells were more ubiquitously distributed (Figure 4
and Video 1). Accordingly, HIV-1–infected human CD4+ T-cells also localized to the bottom third of
villi and in crypt regions, with most infected cells residing in crypts. This spatial distribution
remained consistent, even as human CD4+ andCD8+ T-cell levels changed during the course of
infection (Figure 4D,E). These results suggest that local tissue environments influence cell localiza-
tion and distribution within hu-mice; comparisons between other animal models and human patient
samples will be required to extrapolate these findings.
Adjacent sections of HIV-1–infected GALT were prepared for analysis by ET to gain ultrastructural
information that focused on the establishment and spread of HIV-1 in lymphoid tissues. ET of GALT
from HIV-1–infected PBMC-NSG hu-mice revealed few or no infected cells or virions at 5 days PI,
peak infectivity at 10–16 days PI when infected cells and large pools of free virions were readily
detectable, and reduced numbers of infected cells and sizes of virus pools at >21 days PI (Figure 5).
The ET results were consistent with our IF results and also agree with studies showing the establish-
ment of SIV-infection in GALT and spleen early after infection (Hirao et al., 2014; Williams et al.,
2016).
Hundreds to thousands of free virions accumulating in pools near infected cells in both GALT and
spleen were detected by ET (Figure 5, 7 and Videos 2 and 3), consistent with ET of GALT from HIV-
1–infected BLT hu-mice (Ladinsky et al., 2014). The highest levels of free virus in both GALT and
spleen occurred at 10–12 days PI, a time when virus levels in the blood were low (Figure 3). We
detected pools of free virus contiguous with mucosal vasculature in GALT (Figure 5), and in spleen,
a tissue that acts to filter the blood, we visualized >1000 virions being produced from one region of
an HIV-1–infected cell (Figure 7). We calculated that a single infected cell within tissue could
Video 3. Modeling of an infected cell and individual
virions in spleen Tomographic reconstruction of a
volume of two consecutive 400 nm serial sections of an
HIV-1–infected cell from spleen of a PBMC-NSG animal
12-days PI. Virions are modeled as mature (green),
immature (blue), and budding (magenta). Coiled fibrils
of collagen are evident surrounding the periphery of
the cell and free virions. The second half of the movie
shows zoomed detail. Scale bar = 1 mm.
DOI: 10.7554/eLife.23282.020
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Figure 8. Localization of HIV-1 budding machinery. (A) Densities localized to the base of budding virions. (B) Anti-VPS4A immuno-EM revealing
localization patterns consistent with densities in panel A. (C) Tomographic slice of HIV-1–infected spleen 12 days PI showing large accumulations of
densities (black arrows) adjacent to regions of prolific virus release. (D) Tomographic slices showing budding virions from the animal in panel C
revealing prolific budding (left) or low levels of budding (right). Arrowheads indicate budding virions and arrows indicate densities.
DOI: 10.7554/eLife.23282.021
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produce >6000 virions during a round of virus
release, providing insights into the exponential
production of HIV-1 within tissues early after
infection. The total number of SIV virions pro-
duced by an individual infected cell was previ-
ously estimated to be 4.0–5.4  104
(Chen et al., 2007). If a similar number of HIV-1
virions are produced from infected cells within
tissue, this implies multiple rounds of virus
release from each infected cell, as suggested by
our previous ET studies (Ladinsky et al., 2014).
In lymphoid tissues, the large numbers of target
cells combined with high levels of virus produc-
tion and accessibility to vasculature suggest that
HIV-1–infected cells in tissue provide a source of
free virus that contributes to blood viral load
and systemic spread.
We previously proposed that distinct densi-
ties observed at the base of budding virions dur-
ing virus release contained VPS4
(Ladinsky et al., 2014), an AAA+ ATPase
recruited by polymerized ESCRT-III proteins that
acts to recycle ESCRT-III in conjunction with
Figure 9. Comparison of virion-associated densities, cytoplasmic densities, and densities corresponding to cytoplasmic ribosomes. (A) Representative
tomographic slices of densities associated with budding virions (top), cytoplasmic pools near budding virions (middle), and cytoplasmic ribosomes. (B)
Gallery of images with the same tomographic thickness (9.1 nm) for individual densities associated with budding virions (top), cytoplasmic pools near
budding virions (middle), and cytoplasmic ribosomes. Dimensions of virion-associated and cytoplasmic densities were indistinguishable. Ribosomes
contain a visible cleft between individual subunits that is absent in the densities associated with budding virions and cytoplasmic pools near areas of
prolific virus production.
DOI: 10.7554/eLife.23282.022
Video 4. ET of densities associated with virus budding
Tomographic reconstruction of an accumulation of
cytoplasmic densities associated with prolific virus
release. Densities were present in cytoplasm
immediately adjacent to a region of plasma membrane
supporting prolific virus release and at the base of
budding virions. Scale bar = 0.2 mm.
DOI: 10.7554/eLife.23282.023
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abscission of the nascent virus membrane (Sundquist and Kra¨usslich, 2012). Here we showed
immuno-EM localization of anti-VPS4A antibodies to equivalent regions of budding virions (Figure 8).
In cells undergoing prolific budding, we found aggregations of hundreds to thousands of similar
densities in adjacent regions of cytoplasm within close proximity (<1 mm) to budding virions (Figure 8
and Video 4). Although we could not conclusively identify these densities as containing VPS4, they
differed in size, intensity and shape from ribosomes, which are also distributed throughout the cyto-
plasm (Figures 8 and 9). Notably, the large accumulations of cytoplasmic densities were only pres-
ent in cells undergoing prolific budding (>100 buds), suggesting they are directly involved in HIV-1
assembly and/or budding. Future immuno-EM studies will be required to directly identify their com-
ponents and involvement in the HIV-1 replication cycle.
In summary, the parallel multiscale imaging approaches applied here allowed visualization of early
HIV-1 spread in a hu-mouse model of infection at both single cell and subcellular resolution. 3D-IF of
optically-cleared tissue allowed us to longitudinally and spatially assess the distribution of human
T-cells and virus proteins within volumes of intact lymphoid tissue. ET of adjacent regions of tissue
allowed the detection of individual virions, infected cells, and subcellular protein complexes within
the context of actively-infected tissues at specific times PI. These approaches are directly applicable
to additional lymphoid tissues such as lymph nodes, bone marrow, and thymus in infected hu-mouse,
NHP, and human patient samples. Future efforts will allow the visualization of discreet biological
processes occurring during early HIV-1 spread in lymphoid tissues and enable the development of a
quantifiable spatial map of HIV-1 spread in tissues during early infection.
Materials and methods
Antibodies
Primary antibodies for flow cytometry: mouse monoclonal anti-human CD3-FITC (1:13; Biolegend),
mouse monoclonal anti-human CD4-PE (1:13; Biolegend), mouse monoclonal anti-human CD8a-APC
(1:13; Biolegend). Primary antibodies for IF: rabbit polyclonal anti-human CD3 (1:200; Dako), mouse
monoclonal anti-HIV-1 p24 (1:200; Dako), rabbit polyclonal anti-HIV-1 p24 (1:200; gift of Wesley
Sundquist, University of Utah), mouse monoclonal anti-human CD4-AlexaFluor 488 (1:50; Invitrogen),
mouse monoclonal anti-CD8-PE (1:100; Biolegend). Secondary antibodies for IF: Alexa Fluor 488
goat anti-rabbit IgG, Alexa Fluor 546 goat anti-rabbit IgG, Alexa Fluor 647 goat anti-rabbit IgG,
Alexa Fluor 488 goat anti-mouse IgG, Alexa Fluor 546 goat anti-mouse IgG, Alexa Fluor 647 goat
anti-mouse IgG, Alexa Fluor 488 donkey anti-goat IgG, Alexa Fluor 546 donkey anti-goat IgG, and
Alexa Fluor 647 donkey anti-goat IgG (Invitrogen). All secondary antibodies were used at 1:1000.
For immuno-EM, rabbit monoclonal anti-VPS4A (AbCam) was used at a dilution of 1:500 and 10 nm
gold-conjugated goat anti-rabbit IgG (Ted Pella) was used at a dilution of 1:20.
Flow cytometry of primary and reconstituted human PBMCs
Cultured human PBMCs (AllCells, inc.) were analyzed by flow cytometry (MACSquant) to verify the
presence of T-cell populations as described (Balazs et al., 2012) using antibodies against human
CD3, CD4, and CD8. Lymphocyte populations were identified by forward and side-scatter profiles
and human T-cells were identified by human CD3 staining. Gated human CD3+ T-cell subsets were
evaluated for the presence of human CD4 and CD8 T-cells. Mouse whole blood samples were
treated with RBC lysis/fixation solution (Biolegend) prior to immunostaining and analysis by flow
cytometry as described for cultured huPBMCs.
Humanization and HIV-1 infection of immune deficient mice
NOD.Cg-PrkdscidIl2rgtm1Wjl/SzJ (NOD/SCID/IL2Rg /  or NSG); The Jackson Laboratory) mice were
reconstituted with human PBMCs as previously described (Kumar et al., 2008; Balazs et al., 2012;
Nakata et al., 2005). Briefly, primary human PBMCs (AllCells, inc.) were cultured for 13 days in
RPMI simultaneously supplemented with human IL-2 (R and D Biosystems) and continually stimulated
with phytohemagglutinin-P (Sigma). 2–5  106 cells were injected intraperitoneally into each animal.
Reconstituted animals were retro-orbitally infected with 25 ng R5-tropic HIV-1 (pNL4-3 backbone
pseudotyped with a YU2 envelope obtained from Michel Nussenzweig, Rockefeller University) four
weeks later. Infection was monitored by weekly blood draw and upon sacrifice. Blood samples were
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inactivated with 4% Triton X100 for 1 hr at 37˚C, and p24 levels were quantified by ELISA (Cell Biol-
abs). Assuming 2000 molecules of p24 per virion, and a molecular weight of 24 kDa, there are ~107
HIV virions per nanogram of p24 (http://tronolab.epfl.ch/webdav/site/tronolab/shared/protocols/
TUvsp24.html). Animals were sacrificed by CO2 inhalation followed by cervical dislocation and nec-
ropsied. Lymphoid tissues were excised and immediately placed into cacodylate buffer containing
5% sucrose (Sigma) and 0.1 M sodium cacodylate trihydrate (Sigma) with freshly added 8% parafor-
maldehyde (Electron Microscopy Sciences). Samples were stored in fixative at 4˚C until processed
for LM, EM, or immuno-EM. All animal experiments were approved by the Caltech IACUC.
Tissue clearing
GALT and FRT samples were cleared using the CLARITY/PACT method adapted from
(Treweek et al., 2015). Fixed tissue regions were washed 3x in PBS for 30 min each and incubated
at 4˚C overnight in a hydrogel monomer solution of 10% acrylamide in PBS supplemented with
0.25% photoinitiator VA-044 (2,20 -Azobis[2-(2-imidazolin-2-yl) propane] dihydrochloride; Fischer).
Tissue samples were warmed to room temperature, incubated for 1–3 hr at 37˚C, and monitored for
hydrogel polymerization as indicated by a rapid increase in solution viscosity. Samples were immedi-
ately placed into PBS and washed 3x over the course of several hours. Tissue samples in hydrogel
were placed into conical tubes containing 8% SDS in PBS and incubated for 2–7 days at 37˚C with
shaking. SDS was exchanged daily until samples appeared visually transparent. Cleared tissue hydro-
gel samples were washed 5x in PBS over one day and stored in the dark in PBS at room temperature
for up to 6 months.
Spleen sample were cleared using the CUBIC method adapted from Susaki et al. (2014). Fixed
tissue samples were washed in PBS as described above, placed into CUBIC-1 solution (25% w/v
urea, 25 w/v N,N,N’,N’-tetrakis (2-hydroxypropyl) ethylenediamine (Sigma), 15% w/v polyethylene
glycol mono-p-isooctylphenyl ether/Triton X-100 (Sigma), and incubated at 37˚C with gentle agita-
tion. CUBIC-1 solution was exchanged daily for 3–7 days until tissue was adequately decolorized.
Samples were then washed 5x in PBS over one day, transferred into CUBIC-2 solution (50% w/v
sucrose, 25% w/v urea, 10% w/v 2,2,2’-nitrilotriethanol (Sigma), and 0.1% (v/v) Triton X-100), and
incubated at 37˚C with gentle agitation. CUBIC-2 solution was exchanged daily for 5–10 days until
the tissue appeared visually transparent. CUBIC-2–treated tissue samples were washed 5x in PBS
over one day and either immediately immunostained, stored for up to 6 months in PBS at room tem-
perature in the dark, or frozen and stored long term in optimal cutting temperature compound
(Sakura Finetek) at  80˚C.
Immunostaining
Cleared tissue samples were incubated in blocking buffer (2–4% FBS, 0.1% Tween-20 or Triton
X-100, 0.01% NaN3) overnight at 4˚C. For samples that were immunostained with mouse monoclonal
antibodies, rat anti-mouse CD16/32 (Biolegend) was added to blocking buffer (1:50) to reduce back-
ground. Primary antibody staining was conducted in blocking buffer containing primary antibodies
for 2–3 days. Tissue samples were washed 5x over one day with wash solution (0.1% Tween-20 or Tri-
ton X-100, 0.01% NaN3 in PBS). Samples were then incubated with secondary antibody (1:1000) in
blocking buffer for 2 days and washed 5x over one day in wash solution. To stain for nuclei, washed
tissue samples were incubated in 1 mg/mL 4’,6-diamidino-2-phenylindole (DAPI) in PBS for 8 min.
Samples were washed 3x for 10 min in PBS and incubated overnight in refractive index matching
solution (RIMS) containing 90% Histodenz (Sigma) in 0.02M NaPO4 (Sigma) pH 7.5 buffer supple-
mented with 0.1% Tween-20 and 0.01% NaN3 (Sigma) for CLARITY/PACT-cleared tissues or CUBIC-
2 solution for CUBIC-cleared tissues. All staining and incubations were performed at room tempera-
ture with gentle rocking and kept in the dark after the addition of fluorescent-labeled antibodies.
Confocal IF microscopy and image analysis
Samples were mounted between two No.1 coverslips (Electron Microscopy Sciences) separated by
adhesive/adhesive silicone isolators (Electron Microscopy Sciences) in RIMS for CLARITY samples or
CUBIC-2 solution for CUBIC samples. Mounted samples were imaged with a Zeiss LSM-710 or 880
using a LD LCI Plan-Apochromat 25  0.8 NA Imm Corr DIC M27 multi-immersion objective (w.d.
0.57 mm) with glycerol. Images were analyzed with the Fiji software suite (Schindelin et al., 2012).
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Images were smoothed and individually thresholded to minimize background tissue autofluores-
cence. Nuclei were quantified by thresholding the DAPI channel to show individual nuclei. Images
were smoothed, made binary, and particles >2 mm were analyzed after overlapping nuclei were sep-
arated using the watershed function. Automated nuclei quantification was compared against four
manual counts with >650 individual nuclei per field of view. 3D movies of confocal Z-stacks were
made with the Imaris software suite. Gamma levels for DAPI staining in movies only were thresh-
olded to emphasize CD4, CD8, and p24 cell staining throughout the volume.
Brightfield imaging
Fixed spleen tissues were also used for brightfield imaging. Large slices (~2 mm x 3 mm by x 0.5
mm) of tissue were cut with a microsurgical scalpel and placed on glass slides. Specimens were
imaged with a Diaphot-200 microscope (Nikon, Inc.) using a 4x objective lens in brightfield mode.
Images were recorded digitally.
EM sample preparation
Prefixed lymphoid tissues (described above) were prepared for EM as previously described
(Ladinsky et al., 2014). Briefly, samples were rinsed in cacodylate buffer and trimmed to <~1 mm3
blocks. One to three tissue blocks were placed into brass freezing planchettes (Ted Pella, Inc.) pre-
filled with cacodylate buffer containing 10% Ficoll (Sigma). Samples were rapidly frozen in a HPM-
010 high pressure freezer (Leica Microsystems) and transferred to liquid nitrogen. The planchettes
were placed under liquid nitrogen into cryo tubes (Nunc) containing 2 ml of 2.5% OsO4, 0.05% ura-
nyl acetate in acetone, and then transferred to a AFS2 freeze-substitution machine (Leica Microsys-
tems). Samples were freeze substituted for 72 hr at  90˚C and then warmed to  20˚C over 12 hr.
After 24 hr at  20˚C, the samples were warmed to room temperature, rinsed with acetone, and infil-
trated with Epon-Araldite resin (Electron Microscopy Sciences). Tissue pieces were flat embedded
between two Teflon-coated glass slides and polymerized at 60˚C for 48 hr.
Embedded tissue samples were selected and sectioned as previously described (Ladinsky et al.,
2014). 400 nm sections were cut with a UC6 ultramicrotome (Leica Microsystems) using a diamond
knife (Diatome, Ltd.) and placed on Formvar-coated copper-rhodium 1 mm slot grids (Electron
Microscopy Sciences). Sections were stained with 3% uranyl acetate and lead citrate. Colloidal gold
particles (10 nm) were placed on both surfaces of the grids as fiducial markers. Grids were stabilized
with evaporated carbon prior to imaging.
Electron tomography
Grids were placed in a Dual-Axis Tomography holder (Fischione Instruments, Inc.) and imaged with a
Tecnai TF30ST-FEG microscope (FEI) at 300 KeV. Dual-axis tilt series (±64˚; 1˚ intervals) were
acquired automatically using SerialEM software (Mastronarde, 2008). Tomographic data were
aligned, analyzed and segmented using IMOD (Mastronarde, 2005) on MacPro computers.
Immuno-EM
Prefixed lymphoid tissues were cut into ~1 mm3 blocks and infiltrated with 2.1 M sucrose in cacody-
late buffer over 10 hr. Blocks were affixed to aluminum sectioning stubs and frozen in liquid nitro-
gen. Cryosections (100 nm) were cut with a UC6/FC6 cryoultramicrotome using a Cryo-Immuno
diamond knife (Diatome, Ltd), transferred in a wire loop containing a drop of 2.3 M sucrose in PBS
to Formvar-coated, carbon-coated, glow- discharged 100-mesh copper/rhodium grids, warmed to
room temperature, labeled with primary and colloidal gold secondary antibodies, negatively stained,
and embedded with 1% uranyl acetate, 1% methylcellulose in dH2O. Stained grids were air-dried in
wire loops overnight.
Acknowledgements
We thank Andres Collazo and the Caltech Biological Imaging Center for use of the Zeiss LSM-710
and 880 confocal microscopes and help with image capture and analysis, Carol Garland and Alasdair
McDowall for help maintaining electron microscopes, Viviana Gradinaru and Ben Deverman for
advice about tissue clearing methodologies, Wesley Sundquist for a rabbit polyclonal anti-HIV-1 p24
Kieffer et al. eLife 2017;6:e23282. DOI: 10.7554/eLife.23282 20 of 24
Research article Microbiology and Infectious Disease
antibody, and Michel Nussenzweig for the pNL4-3envYU2 HIV-1. This work was supported by the
National Institutes of Health (2 P50 GM082545-06; WI Sundquist, PI), Ragon Institute and Rosalind
W. Alcott post-doctoral fellowships (CK), gifts from the Gordon and Betty Moore Foundation and
the Agouron Institute to support electron microscopy at Caltech, and funds provided by The
Regents of the University of California, Research Grants Program Office, California HIV/AIDS
Research Program, Grant Number ID15-CT-017. The opinions, findings, and conclusions herein are
those of the author and not necessarily represent those The Regents of the University of California,
or any of its programs.
Additional information
Competing interests
PJB: Reviewing editor, eLife. The other authors declare that no competing interests exist.
Funding
Funder Grant reference number Author
National Institute of General
Medical Sciences
2 P50 GM082545-06 Pamela J Bjorkman
California HIV/AIDS Research
Program
ID15-CT-017 Pamela J Bjorkman
The funders had no role in study design, data collection and interpretation, or the decision to
submit the work for publication.
Author contributions
CK, Conceptualization, Formal analysis, Methodology, Writing—original draft, Writing—review and
editing; MSL, Data curation, Formal analysis, Investigation, Writing—original draft, Writing—review
and editing; AN, Data curation, Methodology, Writing—review and editing; RPG, Conceptualization,
Data curation, Formal analysis, Methodology, Writing—review and editing; PJB, Conceptualization,
Formal analysis, Supervision, Funding acquisition, Writing—original draft, Writing—review and
editing
Author ORCIDs
Pamela J Bjorkman, http://orcid.org/0000-0002-2277-3990
Ethics
Animal experimentation: This study was performed according to the recommendations in the Guide
for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals
were handled according to approved institutional animal care and use committee (IACUC) protocols
(#1702) of the California Institute of Technology. Full effort was made to minimize suffering during
animal sacrifice.
References
Anton PA, Mitsuyasu RT, Deeks SG, Scadden DT, Wagner B, Huang C, Macken C, Richman DD, Christopherson
C, Borellini F, Lazar R, Hege KM. 2003. Multiple measures of HIV burden in blood and tissue are correlated with
each other but not with clinical parameters in aviremic subjects. Aids 17:53–63. doi: 10.1097/00002030-
200301030-00008, PMID: 12478069
Balazs AB, Chen J, Hong CM, Rao DS, Yang L, Baltimore D. 2012. Antibody-based protection against HIV
infection by vectored immunoprophylaxis. Nature 481:81–84. doi: 10.1038/nature10660
Balazs AB, Ouyang Y, Hong CM, Chen J, Nguyen SM, Rao DS, An DS, Baltimore D. 2014. Vectored
immunoprophylaxis protects humanized mice from mucosal HIV transmission. Nature Medicine 20:296–300.
doi: 10.1038/nm.3471, PMID: 24509526
Barre´-Sinoussi F, Chermann JC, Rey F, Nugeyre MT, Chamaret S, Gruest J, Dauguet C, Axler-Blin C, Ve´zinet-
Brun F, Rouzioux C, Rozenbaum W, Montagnier L. 1983. Isolation of a T-lymphotropic retrovirus from a patient
at risk for acquired immune deficiency syndrome (AIDS). Science 220:868–871. doi: 10.1126/science.6189183,
PMID: 6189183
Kieffer et al. eLife 2017;6:e23282. DOI: 10.7554/eLife.23282 21 of 24
Research article Microbiology and Infectious Disease
Belmonte L, Olmos M, Fanin A, Parodi C, Bare´ P, Concetti H, Pe´rez H, de Bracco MM, Cahn P. 2007. The
intestinal mucosa as a reservoir of HIV-1 infection after successful HAART. Aids 21:2106–2108. doi: 10.1097/
QAD.0b013e3282efb74b, PMID: 17885303
Benjamin J, Ganser-Pornillos BK, Tivol WF, Sundquist WI, Jensen GJ. 2005. Three-dimensional structure of HIV-1
virus-like particles by Electron cryotomography. Journal of Molecular Biology 346:577–588. doi: 10.1016/j.jmb.
2004.11.064, PMID: 15670606
Brainard DM, Seung E, Frahm N, Cariappa A, Bailey CC, Hart WK, Shin HS, Brooks SF, Knight HL, Eichbaum Q,
Yang YG, Sykes M, Walker BD, Freeman GJ, Pillai S, Westmoreland SV, Brander C, Luster AD, Tager AM. 2009.
Induction of robust cellular and humoral virus-specific adaptive immune responses in human immunodeficiency
virus-infected humanized BLT mice. Journal of Virology 83:7305–7321. doi: 10.1128/JVI.02207-08, PMID: 1
9420076
Brenchley JM, Schacker TW, Ruff LE, Price DA, Taylor JH, Beilman GJ, Nguyen PL, Khoruts A, Larson M, Haase
AT, Douek DC. 2004. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the
gastrointestinal tract. The Journal of Experimental Medicine 200:749–759. doi: 10.1084/jem.20040874,
PMID: 15365096
Briggs JA, Riches JD, Glass B, Bartonova V, Zanetti G, Kra¨usslich HG. 2009. Structure and assembly of immature
HIV. PNAS 106:11090–11095. doi: 10.1073/pnas.0903535106, PMID: 19549863
Carlson LA, Briggs JA, Glass B, Riches JD, Simon MN, Johnson MC, Mu¨ller B, Gru¨newald K, Kra¨usslich HG. 2008.
Three-dimensional analysis of budding sites and released virus suggests a revised model for HIV-1
morphogenesis. Cell Host & Microbe 4:592–599. doi: 10.1016/j.chom.2008.10.013, PMID: 19064259
Carlson LA, de Marco A, Oberwinkler H, Habermann A, Briggs JA, Kra¨usslich HG, Gru¨newald K. 2010. Cryo
Electron tomography of native HIV-1 budding sites. PLoS Pathogens 6:e1001173. doi: 10.1371/journal.ppat.
1001173, PMID: 21124872
Cerf-Bensussan N, Guy-Grand D. 1991. Intestinal intraepithelial lymphocytes. Gastroenterology Clinics of North
America 20:549–576. PMID: 1917026
Chen HY, Di Mascio M, Perelson AS, Ho DD, Zhang L. 2007. Determination of virus burst size in vivo using a
single-cycle SIV in rhesus macaques. PNAS 104:19079–19084. doi: 10.1073/pnas.0707449104, PMID: 18025463
Chun TW, Carruth L, Finzi D, Shen X, DiGiuseppe JA, Taylor H, Hermankova M, Chadwick K, Margolick J, Quinn
TC, Kuo YH, Brookmeyer R, Zeiger MA, Barditch-Crovo P, Siliciano RF. 1997. Quantification of latent tissue
reservoirs and total body viral load in HIV-1 infection. Nature 387:183–188. doi: 10.1038/387183a0, PMID:
9144289
Chung K, Wallace J, Kim SY, Kalyanasundaram S, Andalman AS, Davidson TJ, Mirzabekov JJ, Zalocusky KA,
Mattis J, Denisin AK, Pak S, Bernstein H, Ramakrishnan C, Grosenick L, Gradinaru V, Deisseroth K. 2013.
Structural and molecular interrogation of intact biological systems. Nature 497:332–337. doi: 10.1038/
nature12107, PMID: 23575631
Denton PW, Estes JD, Sun Z, Othieno FA, Wei BL, Wege AK, Powell DA, Payne D, Haase AT, Garcia JV. 2008.
Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice. PLoS
Medicine 5:e16. doi: 10.1371/journal.pmed.0050016, PMID: 18198941
Diaz LK, Murphy RL, Phair JP, Variakojis D. 2002. The AIDS autopsy spleen: a comparison of the pre-anti-
retroviral and highly active anti-retroviral therapy eras. Modern Pathology 15:406–412. doi: 10.1038/
modpathol.3880538, PMID: 11950914
Earl LA, Lifson JD, Subramaniam S. 2013. Catching HIV ’in the act’ with 3D electron microscopy. Trends in
Microbiology 21:397–404. doi: 10.1016/j.tim.2013.06.004, PMID: 23850373
Fackler OT, Murooka TT, Imle A, Mempel TR. 2014. Adding new dimensions: towards an integrative
understanding of HIV-1 spread. Nature Reviews Microbiology 12:563–574. doi: 10.1038/nrmicro3309,
PMID: 25029025
Gallo RC, Sarin PS, Gelmann EP, Robert-Guroff M, Richardson E, Kalyanaraman VS, Mann D, Sidhu GD, Stahl RE,
Zolla-Pazner S, Leibowitch J, Popovic M. 1983. Isolation of human T-cell leukemia virus in acquired immune
deficiency syndrome (AIDS). Science 220:865–867. doi: 10.1126/science.6601823, PMID: 6601823
Ganusov VV, De Boer RJ. 2007. Do most lymphocytes in humans really reside in the gut? Trends in Immunology
28:514–518. doi: 10.1016/j.it.2007.08.009, PMID: 17964854
Grossman Z, Feinberg MB, Paul WE. 1998. Multiple modes of cellular activation and virus transmission in HIV
infection: a role for chronically and latently infected cells in sustaining viral replication. PNAS 95:6314–6319.
doi: 10.1073/pnas.95.11.6314, PMID: 9600962
Guldner IH, Yang L, Cowdrick KR, Wang Q, Alvarez Barrios WV, Zellmer VR, Zhang Y, Host M, Liu F, Chen DZ,
Zhang S. 2016. An integrative platform for Three-dimensional quantitative analysis of spatially heterogeneous
metastasis landscapes. Scientific Reports 6:24201. doi: 10.1038/srep24201, PMID: 27068335
Guy-Grand D, Vassalli P. 1993. Gut intraepithelial T lymphocytes. Current Opinion in Immunology 5:247–252.
doi: 10.1016/0952-7915(93)90012-H, PMID: 8507401
Haase AT. 1999. Population biology of HIV-1 infection: viral and CD4+ T cell demographics and dynamics in
lymphatic tissues. Annual Review of Immunology 17:625–656. doi: 10.1146/annurev.immunol.17.1.625,
PMID: 10358770
Hatziioannou T, Evans DT. 2012. Animal models for HIV/AIDS research. Nature Reviews Microbiology 10:852–
867. doi: 10.1038/nrmicro2911, PMID: 23154262
Hirao LA, Grishina I, Bourry O, Hu WK, Somrit M, Sankaran-Walters S, Gaulke CA, Fenton AN, Li JA, Crawford
RW, Chuang F, Tarara R, Marco ML, Ba¨umler AJ, Cheng H, Dandekar S. 2014. Early mucosal sensing of SIV
Kieffer et al. eLife 2017;6:e23282. DOI: 10.7554/eLife.23282 22 of 24
Research article Microbiology and Infectious Disease
infection by paneth cells induces IL-1b production and initiates gut epithelial disruption. PLoS Pathogens 10:
e1004311. doi: 10.1371/journal.ppat.1004311, PMID: 25166758
Hur EM, Patel SN, Shimizu S, Rao DS, Gnanapragasam PN, An DS, Yang L, Baltimore D, Ds A. 2012. Inhibitory
effect of HIV-specific neutralizing IgA on mucosal transmission of HIV in humanized mice. Blood 120:4571–
4582. doi: 10.1182/blood-2012-04-422303, PMID: 23065154
Ishikawa F, Yasukawa M, Lyons B, Yoshida S, Miyamoto T, Yoshimoto G, Watanabe T, Akashi K, Shultz LD,
Harada M. 2005. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor
{gamma} chain(null) mice. Blood 106:1565–1573. doi: 10.1182/blood-2005-02-0516, PMID: 15920010
Kilby JM. 2001. Human immunodeficiency virus pathogenesis: insights from studies of lymphoid cells and tissues.
Clinical Infectious Diseases 33:873–884. doi: 10.1086/322647, PMID: 11512093
Kim KC, Choi BS, Kim KC, Park KH, Lee HJ, Cho YK, Kim SI, Kim SS, Oh YK, Kim YB. 2016. A simple mouse
model for the study of human immunodeficiency virus. AIDS Research and Human Retroviruses 32:194–202.
doi: 10.1089/aid.2015.0211, PMID: 26564392
King M, Pearson T, Shultz LD, Leif J, Bottino R, Trucco M, Atkinson MA, Wasserfall C, Herold KC, Woodland RT,
Schmidt MR, Woda BA, Thompson MJ, Rossini AA, Greiner DL. 2008. A new Hu-PBL model for the study of
human islet alloreactivity based on NOD-scid mice bearing a targeted mutation in the IL-2 receptor gamma
chain gene. Clinical Immunology 126:303–314. doi: 10.1016/j.clim.2007.11.001, PMID: 18096436
Kumar P, Ban HS, Kim SS, Wu H, Pearson T, Greiner DL, Laouar A, Yao J, Haridas V, Habiro K, Yang YG, Jeong
JH, Lee KY, Kim YH, Kim SW, Peipp M, Fey GH, Manjunath N, Shultz LD, Lee SK, et al. 2008. T cell-specific
siRNA delivery suppresses HIV-1 infection in humanized mice. Cell 134:577–586. doi: 10.1016/j.cell.2008.06.
034, PMID: 18691745
Ladinsky MS, Kieffer C, Olson G, Deruaz M, Vrbanac V, Tager AM, Kwon DS, Bjorkman PJ. 2014. Electron
tomography of HIV-1 infection in gut-associated lymphoid tissue. PLoS Pathogens 10:e1003899. doi: 10.1371/
journal.ppat.1003899, PMID: 24497830
Lan P, Tonomura N, Shimizu A, Wang S, Yang YG. 2006. Reconstitution of a functional human immune system in
immunodeficient mice through combined human fetal Thymus/liver and CD34+ cell transplantation. Blood 108:
487–492. doi: 10.1182/blood-2005-11-4388, PMID: 16410443
Langeveld M, Gamadia LE, ten Berge IJ. 2006. T-lymphocyte subset distribution in human spleen. European
Journal of Clinical Investigation 36:250–256. doi: 10.1111/j.1365-2362.2006.01626.x, PMID: 16620287
Liu J, Bartesaghi A, Borgnia MJ, Sapiro G, Subramaniam S. 2008. Molecular architecture of native HIV-1 gp120
trimers. Nature 455:109–113. doi: 10.1038/nature07159, PMID: 18668044
Mahalingam M, Peakman M, Davies ET, Pozniak A, McManus TJ, Vergani D. 1993. T cell activation and disease
severity in HIV infection. Clinical and Experimental Immunology 93:337–343. doi: 10.1111/j.1365-2249.1993.
tb08182.x, PMID: 8103715
Marsden MD, Zack JA. 2015. Studies of retroviral infection in humanized mice. Virology 479-480:297–309.
doi: 10.1016/j.virol.2015.01.017, PMID: 25680625
Mastronarde DN. 2005. Automated Electron microscope tomography using robust prediction of specimen
movements. Journal of Structural Biology 152:36–51. doi: 10.1016/j.jsb.2005.07.007, PMID: 16182563
Mastronarde DN. 2008. Correction for non-perpendicularity of beam and tilt Axis in tomographic
reconstructions with the IMOD package. Journal of Microscopy 230:212–217. doi: 10.1111/j.1365-2818.2008.
01977.x, PMID: 18445149
McElrath MJ, Smythe K, Randolph-Habecker J, Melton KR, Goodpaster TA, Hughes SM, Mack M, Sato A, Diaz
G, Steinbach G, Novak RM, Curlin ME, Curlin M, Lord JD, Maenza J, Duerr A, Frahm N, Hladik F, NIAID HIV
Vaccine Trials Network. 2013. Comprehensive assessment of HIV target cells in the distal human gut suggests
increasing HIV susceptibility toward the anus. JAIDS Journal of Acquired Immune Deficiency Syndromes 63:
263–271. doi: 10.1097/QAI.0b013e3182898392, PMID: 23392465
McIntosh R, Nicastro D, Mastronarde D. 2005. New views of cells in 3D: an introduction to Electron tomography.
Trends in Cell Biology 15:43–51. doi: 10.1016/j.tcb.2004.11.009, PMID: 15653077
Mebius RE, Kraal G. 2005. Structure and function of the spleen. Nature Reviews Immunology 5:606–616. doi: 10.
1038/nri1669, PMID: 16056254
Mehandru S, Poles MA, Tenner-Racz K, Horowitz A, Hurley A, Hogan C, Boden D, Racz P, Markowitz M. 2004.
Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in
the gastrointestinal tract. The Journal of Experimental Medicine 200:761–770. doi: 10.1084/jem.20041196,
PMID: 15365095
Melkus MW, Estes JD, Padgett-Thomas A, Gatlin J, Denton PW, Othieno FA, Wege AK, Haase AT, Garcia JV.
2006. Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1. Nature
Medicine 12:1316–1322. doi: 10.1038/nm1431, PMID: 17057712
Mestecky J, Moldoveanu Z, Smith PD, Hel Z, Alexander RC. 2009. Mucosal immunology of the genital and
gastrointestinal tracts and HIV-1 infection. Journal of Reproductive Immunology 83:196–200. doi: 10.1016/j.jri.
2009.07.005, PMID: 19853927
Mohan M, Aye PP, Borda JT, Alvarez X, Lackner AA. 2007. Gastrointestinal disease in simian immunodeficiency
virus-infected rhesus macaques is characterized by proinflammatory dysregulation of the interleukin-6-Janus
kinase/signal transducer and activator of transcription3 pathway. The American Journal of Pathology 171:1952–
1965. doi: 10.2353/ajpath.2007.070017, PMID: 18055558
Monroe N, Han H, Gonciarz MD, Eckert DM, Karren MA, Whitby FG, Sundquist WI, Hill CP. 2014. The oligomeric
state of the active Vps4 AAA ATPase. Journal of Molecular Biology 426:510–525. doi: 10.1016/j.jmb.2013.09.
043, PMID: 24161953
Kieffer et al. eLife 2017;6:e23282. DOI: 10.7554/eLife.23282 23 of 24
Research article Microbiology and Infectious Disease
Mosier DE, Gulizia RJ, Baird SM, Wilson DB. 1988. Transfer of a functional human immune system to mice with
severe combined immunodeficiency. Nature 335:256–259. doi: 10.1038/335256a0, PMID: 2970594
Nakata H, Maeda K, Miyakawa T, Shibayama S, Matsuo M, Takaoka Y, Ito M, Koyanagi Y, Mitsuya H. 2005.
Potent anti-R5 human immunodeficiency virus type 1 effects of a CCR5 antagonist, AK602/ONO4128/
GW873140, in a novel human peripheral blood mononuclear cell nonobese diabetic-SCID, interleukin-2
receptor gamma-chain-knocked-out AIDS mouse model. Journal of Virology 79:2087–2096. doi: 10.1128/JVI.
79.4.2087-2096.2005, PMID: 15681411
Orenstein JM. 2007. Replication of HIV-1 in vivo and in vitro. Ultrastructural Pathology 31:151–167. doi: 10.
1080/01913120701344343, PMID: 17613995
Reinhart TA, Rogan MJ, Huddleston D, Rausch DM, Eiden LE, Haase AT. 1997. Simian immunodeficiency virus
burden in tissues and cellular compartments during clinical latency and AIDS. The Journal of Infectious Diseases
176:1198–1208. doi: 10.1086/514113, PMID: 9359719
Richardson DS, Lichtman JW. 2015. Clarifying tissue clearing. Cell 162:246–257. doi: 10.1016/j.cell.2015.06.067,
PMID: 26186186
Saksena NK, Wang B, Zhou L, Soedjono M, Ho YS, Conceicao V. 2010. HIV reservoirs in vivo and new strategies
for possible eradication of HIV from the reservoir sites. HIV/AIDS - Research and Palliative Care 2:103–122.
doi: 10.2147/HIV.S6882, PMID: 22096389
Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S,
Schmid B, Tinevez JY, White DJ, Hartenstein V, Eliceiri K, Tomancak P, Cardona A. 2012. Fiji: an open-source
platform for biological-image analysis. Nature Methods 9:676–682. doi: 10.1038/nmeth.2019, PMID: 22743772
Shultz LD, Lyons BL, Burzenski LM, Gott B, Chen X, Chaleff S, Kotb M, Gillies SD, King M, Mangada J, Greiner
DL, Handgretinger R. 2005. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null
mice engrafted with mobilized human hemopoietic stem cells. The Journal of Immunology 174:6477–6489.
doi: 10.4049/jimmunol.174.10.6477, PMID: 15879151
Sun Z, Denton PW, Estes JD, Othieno FA, Wei BL, Wege AK, Melkus MW, Padgett-Thomas A, Zupancic M,
Haase AT, Garcia JV. 2007. Intrarectal transmission, systemic infection, and CD4+ T cell depletion in humanized
mice infected with HIV-1. The Journal of Experimental Medicine 204:705–714. doi: 10.1084/jem.20062411,
PMID: 17389241
Sundquist WI, Kra¨usslich HG. 2012. HIV-1 assembly, budding, and maturation. Cold Spring Harbor Perspectives
in Medicine 2:a006924. doi: 10.1101/cshperspect.a006924, PMID: 22762019
Susaki EA, Tainaka K, Perrin D, Kishino F, Tawara T, Watanabe TM, Yokoyama C, Onoe H, Eguchi M, Yamaguchi
S, Abe T, Kiyonari H, Shimizu Y, Miyawaki A, Yokota H, Ueda HR. 2014. Whole-brain imaging with single-cell
resolution using chemical cocktails and computational analysis. Cell 157:726–739. doi: 10.1016/j.cell.2014.03.
042, PMID: 24746791
Tainaka K, Kubota SI, Suyama TQ, Susaki EA, Perrin D, Ukai-Tadenuma M, Ukai H, Ueda HR. 2014. Whole-body
imaging with single-cell resolution by tissue decolorization. Cell 159:911–924. doi: 10.1016/j.cell.2014.10.034,
PMID: 25417165
Tainaka K, Kuno A, Kubota SI, Murakami T, Ueda HR. 2016. Chemical principles in tissue clearing and staining
protocols for Whole-Body cell profiling. Annual Review of Cell and Developmental Biology 32:713–741. doi: 10.
1146/annurev-cellbio-111315-125001, PMID: 27298088
Tomer R, Ye L, Hsueh B, Deisseroth K. 2014. Advanced CLARITY for rapid and high-resolution imaging of intact
tissues. Nature Protocols 9:1682–1697. doi: 10.1038/nprot.2014.123, PMID: 24945384
Tomer R, Lovett-Barron M, Kauvar I, Andalman A, Burns VM, Sankaran S, Grosenick L, Broxton M, Yang S,
Deisseroth K. 2015. SPED light sheet microscopy: fast mapping of biological system structure and function. Cell
163:1796–1806. doi: 10.1016/j.cell.2015.11.061, PMID: 26687363
Treweek JB, Chan KY, Flytzanis NC, Yang B, Deverman BE, Greenbaum A, Lignell A, Xiao C, Cai L, Ladinsky MS,
Bjorkman PJ, Fowlkes CC, Gradinaru V. 2015. Whole-body tissue stabilization and selective extractions via
tissue-hydrogel hybrids for high-resolution intact circuit mapping and phenotyping. Nature Protocols 10:1860–
1896. doi: 10.1038/nprot.2015.122, PMID: 26492141
Treweek JB, Gradinaru V. 2016. Extracting structural and functional features of widely distributed biological
circuits with single cell resolution via tissue clearing and delivery vectors. Current Opinion in Biotechnology 40:
193–207. doi: 10.1016/j.copbio.2016.03.012, PMID: 27393829
UNAIDS. 2015. How AIDS Changed Everything. World Health Organization.
Williams DW, Engle EL, Shirk EN, Queen SE, Gama L, Mankowski JL, Zink MC, Clements JE. 2016. Splenic
damage during SIV infection: role of T-Cell depletion and macrophage polarization and infection. The American
Journal of Pathology 186:2068–2087. doi: 10.1016/j.ajpath.2016.03.019, PMID: 27322772
Wright ER, Schooler JB, Ding HJ, Kieffer C, Fillmore C, Sundquist WI, Jensen GJ. 2007. Electron
cryotomography of immature HIV-1 virions reveals the structure of the CA and SP1 gag shells. The EMBO
Journal 26:2218–2226. doi: 10.1038/sj.emboj.7601664, PMID: 17396149
Yang B, Treweek JB, Kulkarni RP, Deverman BE, Chen CK, Lubeck E, Shah S, Cai L, Gradinaru V. 2014. Single-cell
phenotyping within transparent intact tissue through whole-body clearing. Cell 158:945–958. doi: 10.1016/j.
cell.2014.07.017, PMID: 25088144
Zhu P, Liu J, Bess J, Chertova E, Lifson JD, Grise´ H, Ofek GA, Taylor KA, Roux KH. 2006. Distribution and three-
dimensional structure of AIDS virus envelope spikes. Nature 441:847–852. doi: 10.1038/nature04817,
PMID: 16728975
Kieffer et al. eLife 2017;6:e23282. DOI: 10.7554/eLife.23282 24 of 24
Research article Microbiology and Infectious Disease
